Robert D. Morgan

Alderley Park
Macclesfield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Risk of breast cancer after ovarian cancer in germline BRCA1/2 heterozygotes.

Risk of breast cancer after ovarian cancer in germline BRCA1/2 heterozygotes.

Journal: Journal of medical genetics

Published: May 15, 2026

Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK.

Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK.

Journal: EClinicalMedicine

Published: April 09, 2026

Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis.

Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis.

Journal: American journal of obstetrics and gynecology

Published: October 21, 2025

Racial disparities in ovarian cancer survival transcend the somatic mutational landscape.

Racial disparities in ovarian cancer survival transcend the somatic mutational landscape.

Journal: Translational cancer research

Published: September 24, 2025

Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study.

Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study.

Journal: Clinical colorectal cancer

Published: May 30, 2025

Proposed Standards for the Use of CO2 in Dialysis Access Interventions.

Proposed Standards for the Use of CO2 in Dialysis Access Interventions.

Journal: Cardiovascular and interventional radiology

Published: May 26, 2025

Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma.

Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma.

Journal: Journal of medical genetics

Published: May 05, 2025

Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer.

Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer.

Journal: Journal of medical genetics

Published: April 19, 2025

Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancer.

Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancer.

Journal: Cell reports. Medicine

Published: October 25, 2024

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom.

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 02, 2024

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.

Journal: British journal of cancer

Published: May 26, 2024

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 09, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026